Navigation Links
U.S. FDA Approves New Oral Contraceptive That Also Raises Folate Levels
Date:9/24/2010

;, Avapro®, and others), aldosterone antagonists, and heparin.

What are the Most Common Side Effects?

In clinical trials, the most common side effects were headache/migraine, menstrual irregularities, nausea/vomiting, breast pain/tenderness, fatigue, irritability, decreased libido, weight gain and mood changes.

Beyaz does not protect against HIV infection (AIDS) or other STDs.

YAZ® and YASMIN® Indications & Usage

YASMIN® (drospirenone 3 mg & ethinyl estradiol 30 mcg) is indicated for the prevention of pregnancy in women who elect to use an oral contraceptive.

YAZ® (drospirenone 3 mg & ethinyl estradiol 20 mcg) is indicated for:

  • The prevention of pregnancy in women who elect to use an oral contraceptive.
  • Treatment of the emotional and physical symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception.
    • The effectiveness of YAZ for PMDD when used for more than 3 menstrual cycles has not been evaluated. YAZ has not been evaluated for the treatment of premenstrual syndrome (PMS).
  • Treatment of moderate acne vulgaris
    • In women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. YAZ should be used for the treatment of moderate acne only if the patient desires an oral contraceptive for birth control.

Important Safety Information About YAZ® and YASMIN®

Who Shouldn't Take Any Oral Contraceptives (OCs)? Some women should not use OCs, including women who have blood clots, certain cancers, a history of heart attack or stroke, as well a
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
2. FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
3. FDA Approves Pediatric Use of Chemical Poisoning Treatment
4. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
5. FDA Approves Vaccines for the 2010-2011 Influenza Season
6. FDA Approves Strativa Pharmaceuticals Zuplenz® (ondansetron) Oral Soluble Film
7. FDA Approves Sagent Pharmaceuticals Heparin Sodium Injection, USP
8. U.S. FDA Approves Improved Performance of Riverain Medicals OnGuard Chest X-ray Computer-Aided Detection Technology
9. FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
10. FDA Approves New Treatment for Late-Onset Pompe Disease
11. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Thoratec Corporation (NASDAQ: ... support therapies to save, support and restore failing hearts, ... Morgan Stanley Global Healthcare Conference on Wednesday, September 10. ... Chief Executive Officer, will provide an update on the ... a.m., Pacific Daylight Time).   A webcast ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "China Orthopedic Instrument Industry Report, 2014-2017" ... accelerated aging population and rising proportion of reimbursement for ... been effectively released, with its scale presenting a CAGR ... joint products are three product segments of orthopedic instruments ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets  has ... Pipeline Insight 2014" report to their offering. ... is one of the largest segments of pharmaceuticals industry. The ... while the available therapies were unable to meet the market ... market for CNS disorder, especially over the past two decades. ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
(Date:8/30/2014)... August 30, 2014 In today’s world, ... increasingly difficult to get. Snoring and sleep apnea (a ... breathing stops) robs people and their bed partners of ... Up to 45% of the population snores and 20 ... apnea. Of these, only 10% have been diagnosed and ...
(Date:8/30/2014)... 2014 August 28th, 2014: With ... our society and the toll that takes on the ... that continuing education for physical therapists addresses this problem. ... therapists help others, Hands-On Seminars is offering discounts on ... Three learning styles are available to fit the individual ...
(Date:8/30/2014)... FL (PRWEB) August 30, 2014 McLeod's ... full service auto repair shop with strong ties to the ... Family is happy to announce they have been chosen by ... one pick for auto repair. , Tim McLeod’s father, ... Auto Service sixty years ago. Although his son, Tim runs ...
(Date:8/30/2014)... 2014 The SI Joint Evaluation and ... six muscle energy techniques. Michael P. Reiman PT, DPT, ... examination techniques for the SI Joint. This ... live course presentation with North American Seminars. ... Applying a differential diagnosis approach to a thorough examination ...
(Date:8/30/2014)... 30, 2014 What challenges exist in ... the latest trends, concerns, and considerations? Sports Conflict ... Pendleton recently spoke with Woody Wommack, Southeast Football Recruiting ... issues in football recruiting. Notably, Wommack spoke on ... changes that he thinks are coming as a result ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:McLeod's Sunset Park Auto Service Celebrates 60 Years Honored with Best of South Tampa 2Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 3
... Response Systems,announced today two new contract awards, worth ... surge capacity for hospitals and,public health systems in ... Suffolk County, NY., The first contract, for ... the Idaho Central District Health Department. This,contract includes ...
... of connecting with doctors in real time, speeding care, study ... patients report to doctors on their symptoms and side effects ... Even the sickest cancer patients are willing and capable of ... Cancer Center in New York City. , "Cancer care has ...
... Omnicell, Inc.,(Nasdaq: OMCL ), a leading ... announced that it has entered into a definitive ... cash transaction valued at,approximately $26 million, subject to ... that brings quality healthcare to the,bedside through a ...
... rate of decline in lung function in children and adolescents ... Researchers found that patients with cystic fibrosis (CF) who took ... loss of lung function compared to those who did not ... two to seven years. , It is fairly evident ...
... Assay Developed Specifically for Resource-Limited ... Settings Joins Global Procurement Consortium, UPPSALA, Sweden, November ... today announced an agreement with the Clinton,Foundation HIV/AIDS Initiative ... immediately available to members of CHAI,s,Procurement Consortium at a ...
... Nov. 29 AstraZeneca (NYSE:,AZN) today announced that the ... an additional six-month period of,exclusivity to market ARIMIDEX(R) (anastrozole) ... to pediatric exclusivity being,granted by the FDA, the patent ... is currently approved in the US for the for ...
Cached Medicine News:Health News:BLU-MED Announces New Medical Preparedness Contracts 2Health News:Cancer Patients Gain From Reporting Symptoms Online 2Health News:Omnicell Announces Agreement to Acquire Rioux Vision, Inc. 2Health News:Omnicell Announces Agreement to Acquire Rioux Vision, Inc. 3Health News:Ibuprofen associated with slower lung function decline in children with cystic fibrosis 2Health News:Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring 2Health News:Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring 3Health News:AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA 2Health News:AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA 3
... Laserex Super Q is an Nd: YAG ... and reliable means for performing posterior capsulotomy, ... Q delivers benchmark performance in an elegant, ... Laserex Super Q produces a 1064 nm ...
... Ultrasonix ES500 system is an innovative, ... that provides excellent clinical performance. The ... processing of the ES500 system deliver ... and every system offers a full ...
Protects the eye during or after surgery or trauma. Smooth edges need no protective cover. Connected with elastic at nose. Adjustable hook/loop material for a comfortable fit....
Protects the eye during or after surgery or trauma...
Medicine Products: